253 related articles for article (PubMed ID: 12814678)
1. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality.
Baltaci S; Orhan D; Göğüş C; Filiz E; Tulunay O; Göğüş O
Eur Urol; 2003 Jul; 44(1):76-81; discussion 81. PubMed ID: 12814678
[TBL] [Abstract][Full Text] [Related]
2. Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas.
Oh CK; Kwon YW; Kim YS; Jang HS; Kwon KS
J Dermatol; 2003 Apr; 30(4):306-13. PubMed ID: 12707467
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases.
Zhang X; Yamashita M; Uetsuki H; Kakehi Y
Int J Urol; 2002 Sep; 9(9):509-14. PubMed ID: 12410931
[TBL] [Abstract][Full Text] [Related]
4. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma.
Maeda K; Nishiguchi Y; Yashiro M; Yamada S; Onoda N; Sawada T; Kang SM; Hirakawa K
Int J Mol Med; 2000 Apr; 5(4):373-8. PubMed ID: 10719053
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia.
Kwak C; Jin RJ; Lee C; Park MS; Lee SE
BJU Int; 2002 Feb; 89(3):303-9. PubMed ID: 11856116
[TBL] [Abstract][Full Text] [Related]
7. Histopathological analysis of angiogenic factors in renal cell carcinoma.
Yagasaki H; Kawata N; Takimoto Y; Nemoto N
Int J Urol; 2003 Apr; 10(4):220-7. PubMed ID: 12657102
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma.
Chhieng DC; Tabbara SO; Marley EF; Talley LI; Frost AR
Breast J; 2003; 9(3):200-7. PubMed ID: 12752628
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Oka S; Hiyama T; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2003 Oct; 23(4):901-11. PubMed ID: 12963968
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor in renal cell carcinomas.
Paradis V; Lagha NB; Zeimoura L; Blanchet P; Eschwege P; Ba N; Benoît G; Jardin A; Bedossa P
Virchows Arch; 2000 Apr; 436(4):351-6. PubMed ID: 10834538
[TBL] [Abstract][Full Text] [Related]
12. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
Salvesen HB; Akslen LA
Int J Cancer; 1999 Oct; 84(5):538-43. PubMed ID: 10502735
[TBL] [Abstract][Full Text] [Related]
13. Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma.
Choi JH; Ahn MJ; Jang SJ; Park CK; Park YW; Oh HS; Lee YY; Choi IY; Kim IS
Int J Hematol; 2002 Dec; 76(5):460-4. PubMed ID: 12512841
[TBL] [Abstract][Full Text] [Related]
14. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
[TBL] [Abstract][Full Text] [Related]
15. [Expression of VEGF and tumor angiogenesis in bladder cancer].
Wang S; Xia T; Zhang Z; Kong X; Zeng L; Mi P; Xue Z
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):34-6. PubMed ID: 11831983
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
Niedergethmann M; Hildenbrand R; Wolf G; Verbeke CS; Richter A; Post S
Int J Pancreatol; 2000 Aug; 28(1):31-9. PubMed ID: 11185708
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer.
Song ZJ; Gong P; Wu YE
World J Gastroenterol; 2002 Aug; 8(4):591-5. PubMed ID: 12174362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]